Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Detection and activation of HIV broadly neutralizing antibody precursor B cells using anti-idiotypes

Journal Article · · Journal of Experimental Medicine
DOI:https://doi.org/10.1084/jem.20190164· OSTI ID:1562601
 [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [1];  [2];  [3];  [3];  [3];  [1];  [3];  [1];  [4];  [4];  [5]
  1. Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA
  2. Basic Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA
  3. Department of Immunology and Microbial Science, The Scripps Research Institute, La Jolla, CA
  4. Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, Department of Global Health, University of Washington, Seattle, WA
  5. Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, Department of Global Health, University of Washington, Seattle, WA, Department of Immunology, University of Washington, Seattle, WA
Many tested vaccines fail to provide protection against disease despite the induction of antibodies that bind the pathogen of interest. In light of this, there is much interest in rationally designed subunit vaccines that direct the antibody response to protective epitopes. Here, we produced a panel of anti-idiotype antibodies able to specifically recognize the inferred germline version of the human immunodeficiency virus 1 (HIV-1) broadly neutralizing antibody b12 (iglb12). We determined the crystal structure of two anti-idiotypes in complex with iglb12 and used these anti-idiotypes to identify rare naive human B cells expressing B cell receptors with similarity to iglb12. Immunization with a multimerized version of this anti-idiotype induced the proliferation of transgenic murine B cells expressing the iglb12 heavy chain in vivo, despite the presence of deletion and anergy within this population. Together, our data indicate that anti-idiotypes are a valuable tool for the study and induction of potentially protective antibodies.
Research Organization:
Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
Sponsoring Organization:
James B. Pendleton Charitable Trust; National Institute of Allergy and Infectious Diseases (NIAID); National Institute of General Medical Sciences (NIGMS); National Institutes of Health (NIH); USDOE Office of Science (SC), Basic Energy Sciences (BES)
Grant/Contract Number:
AC02-05CH11231
OSTI ID:
1562601
Alternate ID(s):
OSTI ID: 1625202
Journal Information:
Journal of Experimental Medicine, Journal Name: Journal of Experimental Medicine Journal Issue: 10 Vol. 216; ISSN 0022-1007
Country of Publication:
United States
Language:
English

References (119)

[20] Processing of X-ray diffraction data collected in oscillation mode book January 1997
Unraveling hot spots in binding interfaces: progress and challenges journal February 2002
The “Clonal Selection Hypothesis” and Current Concepts of B Cell Tolerance journal September 1996
Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: Implications for evasion of immune responses and design of vaccine immunogens journal December 2009
Germinal Center Dynamics Revealed by Multiphoton Microscopy with a Photoactivatable Fluorescent Reporter journal November 2010
Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization journal March 2013
Structural Insights on the Role of Antibodies in HIV-1 Vaccine and Therapy journal February 2014
Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors journal June 2015
Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin Mice journal June 2015
Sequential Immunization Elicits Broadly Neutralizing Anti-HIV-1 Antibodies in Ig Knockin Mice journal September 2016
Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico journal May 2017
Antibody 27F3 Broadly Targets Influenza A Group 1 and 2 Hemagglutinins through a Further Variation in V H 1-69 Antibody Orientation on the HA Stem journal September 2017
Identification of Anergic B Cells within a Wild-Type Repertoire journal December 2006
Germinal-Center Organization and Cellular Dynamics journal August 2007
Bcl6 Protein Expression Shapes Pre-Germinal Center B Cell Dynamics and Follicular Helper T Cell Heterogeneity journal June 2011
Identification of Common Features in Prototype Broadly Neutralizing Antibodies to HIV Envelope V2 Apex to Facilitate Vaccine Design journal November 2015
HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies journal September 2016
Precursor Frequency and Affinity Determine B Cell Competitive Fitness in Germinal Centers, Tested with Germline-Targeting HIV Vaccine Immunogens journal January 2018
Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation journal February 2018
An Antibody Targeting the Fusion Machinery Neutralizes Dual-Tropic Infection and Defines a Site of Vulnerability on Epstein-Barr Virus journal April 2018
HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure journal May 2018
Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning journal January 2008
Cloning and expression of murine Ig genes from single B cells journal October 2009
Arranged Sevenfold: Structural Insights into the C-Terminal Oligomerization Domain of Human C4b-Binding Protein journal April 2013
Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice journal August 1988
Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire journal September 1994
Neutralizing antibody directed against the HIV–1 envelope glycoprotein can completely block HIV–1/SIV chimeric virus infections of macaque monkeys journal February 1999
Structural definition of a conserved neutralization epitope on HIV-1 gp120 journal February 2007
Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals journal March 2009
Broad neutralization coverage of HIV by multiple highly potent antibodies journal September 2011
Broad and potent neutralization of HIV-1 by a gp41-specific human antibody journal September 2012
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus journal April 2013
Broad and potent HIV-1 neutralization by a human antibody that binds the gp41–gp120 interface journal September 2014
Structure and immune recognition of trimeric pre-fusion HIV-1 Env journal October 2014
A single injection of anti-HIV-1 antibodies protects against repeated SHIV challenges journal April 2016
B-cell–lineage immunogen design in vaccine development with HIV-1 as a case study journal May 2012
Specifically modified Env immunogens activate B-cell precursors of broadly neutralizing HIV-1 antibodies in transgenic mice journal February 2016
Efficient generation of monoclonal antibodies against peptide in the context of MHCII using magnetic enrichment journal June 2016
IgD attenuates the IgM-induced anergy response in transitional and mature B cells journal November 2016
Control systems and decision making for antibody production journal July 2010
HIV vaccine design and the neutralizing antibody problem journal March 2004
Vectored immunoprophylaxis protects humanized mice from mucosal HIV transmission journal February 2014
Determinants of HIV-1 broadly neutralizing antibody induction journal September 2016
Correlates of immune protection in HIV-1 infection: what we know, what we don't know, what we should know journal August 2004
Mechanisms of central tolerance for B cells journal April 2017
Receptor editing in lymphocyte development and central tolerance journal October 2006
Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning journal August 2013
Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses journal February 2009
Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design journal December 2015
Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies journal March 2019
Passive Transfer of A Germline-like Neutralizing Human Monoclonal Antibody Protects Transgenic Mice Against Lethal Middle East Respiratory Syndrome Coronavirus Infection journal August 2016
Combinatorial antibody libraries from survivors of the Turkish H5N1 avian influenza outbreak reveal virus neutralization strategies journal April 2008
Autoreactivity in an HIV-1 broadly reactive neutralizing antibody variable region heavy chain induces immunologic tolerance journal December 2009
Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention journal February 2012
A mouse model for HIV-1 entry journal September 2012
Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo journal October 2012
Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies journal October 2012
Large-scale sequence and structural comparisons of human naive and antigen-experienced antibody repertoires journal April 2016
A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. journal November 1991
Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro. journal October 1992
Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: Clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant journal December 1997
An inverse relationship between T cell receptor affinity and antigen dose during CD4+ T cell responses in vivo and in vitro journal August 1999
Reduced life span of anergic self-reactive B cells in a double- transgenic model journal January 1994
Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells journal February 1994
Deletion and anergy of polyclonal B cells specific for ubiquitous membrane-bound self-antigen journal October 2012
Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies journal March 2013
Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques journal August 2014
Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design journal March 2016
Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus journal November 1997
Daedalus: a robust, turnkey platform for rapid production of decigram quantities of active recombinant proteins in human cell lines using novel lentiviral vectors journal September 2011
Coot model-building tools for molecular graphics journal November 2004
PHENIX: a comprehensive Python-based system for macromolecular structure solution journal January 2010
The CCP4 suite programs for protein crystallography journal September 1994
Transitional B cell subsets in human bone marrow: Transitional B cell subsets in human bone marrow journal September 2013
HIV-1 neutralizing antibodies: understanding nature's pathways journal June 2013
T cells and follicular dendritic cells in germinal center B-cell formation and selection: Roles of T cells and FDCs in germinal centers journal August 2010
Unique properties of memory B cells of different isotypes: Memory B cells of different isotypes journal August 2010
Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies journal June 2005
Antibody Recognition of a Highly Conserved Influenza Virus Epitope journal April 2009
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target journal September 2009
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1 journal July 2010
Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01 journal July 2010
A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses journal July 2011
A Neutralizing Antibody Selected from Plasma Cells That Binds to Group 1 and Group 2 Influenza A Hemagglutinins journal July 2011
Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding journal July 2011
Highly Conserved Protective Epitopes on Influenza B Viruses journal August 2012
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors journal March 2013
Antibodies in HIV-1 Vaccine Development and Therapy journal September 2013
Antigen modification regulates competition of broad and narrow neutralizing HIV antibodies journal December 2014
Apoptosis and antigen affinity limit effector cell differentiation of a single naive B cell journal January 2015
Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen journal June 2015
HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen journal March 2016
Antibody-mediated protection against SHIV challenge includes systemic clearance of distal virus journal August 2016
Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera journal October 2015
Immune history profoundly affects broadly protective B cell responses to influenza journal December 2015
Initiation of immune tolerance–controlled HIV gp41 neutralizing B cell lineages journal April 2016
The Oligomerization Domain of C4-Binding Protein (C4bp) Acts as an Adjuvant, and the Fusion Protein Comprised of the 19-Kilodalton Merozoite Surface Protein 1 Fused with the Murine C4bp Domain Protects Mice against Malaria journal May 2008
Antibody and Antiretroviral Preexposure Prophylaxis Prevent Cervicovaginal HIV-1 Infection in a Transgenic Mouse Model journal May 2013
HIV-1 Subtype C-Infected Children with Exceptional Neutralization Breadth Exhibit Polyclonal Responses Targeting Known Epitopes journal June 2018
Crystal Structure of PG16 and Chimeric Dissection with Somatically Related PG9: Structure-Function Analysis of Two Quaternary-Specific Antibodies That Effectively Neutralize HIV-1 journal June 2010
Structure of a Classical Broadly Neutralizing Stem Antibody in Complex with a Pandemic H2 Influenza Virus Hemagglutinin journal April 2013
Diverse Recombinant HIV-1 Envs Fail To Activate B Cells Expressing the Germline B Cell Receptors of the Broadly Neutralizing Anti-HIV-1 Antibodies PG9 and 447-52D journal December 2013
Protection of Macaques against Pathogenic Simian/Human Immunodeficiency Virus 89.6PD by Passive Transfer of Neutralizing Antibodies journal January 1999
Antibody Protects Macaques against Vaginal Challenge with a Pathogenic R5 Simian/Human Immunodeficiency Virus at Serum Levels Giving Complete Neutralization In Vitro journal September 2001
The Broadly Neutralizing Anti-Human Immunodeficiency Virus Type 1 Antibody 2G12 Recognizes a Cluster of  1->2 Mannose Residues on the Outer Face of gp120 journal July 2002
Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function. journal January 1989
A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains. journal January 1993
Broadly Neutralizing Antibodies to HIV and Their Role in Vaccine Design journal May 2016
Novel HIV vaccine strategies: overview and perspective journal July 2013
Development of prophylactic vaccines against HIV-1 journal January 2013
Heterosubtypic Neutralizing Monoclonal Antibodies Cross-Protective against H5N1 and H1N1 Recovered from Human IgM+ Memory B Cells journal December 2008
Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers journal May 2009
Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs journal January 2013
Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort journal January 2016
B Cells from Knock-in Mice Expressing Broadly Neutralizing HIV Antibody b12 Carry an Innocuous B Cell Receptor Responsive to HIV Vaccine Candidates journal August 2013
Immune Tolerance Negatively Regulates B Cells in Knock-In Mice Expressing Broadly Neutralizing HIV Antibody 4E10 journal August 2013
Cutting Edge: Introduction of an Endopeptidase Cleavage Motif into a Determinant Flanking Region of Hen Egg Lysozyme Results in Enhanced T Cell Determinant Display journal July 2000
Resolution of Three Nonproliferative Immature Splenic B Cell Subsets Reveals Multiple Selection Points During Peripheral B Cell Maturation journal December 2001
Therapeutic antibodies, vaccines and antibodyomes journal May 2010

Similar Records

Anti-idiotypic antibodies elicit anti-HIV-1–specific B cell responses
Journal Article · Wed Jul 24 20:00:00 EDT 2019 · Journal of Experimental Medicine · OSTI ID:1562602